Tim Edwards  Executive Chairman

Tim joined Karus as Executive Chairman in 2018. He has extensive management and advisory experience in the biopharmaceutical industry. As well as his role at Karus, Tim is a Director of Ervaxx Limited, a privately-held company developing first-in-…

Read more

Stephen Shuttleworth  Chief Operating Officer and Chief Scientific Officer

Stephen joined Karus as CSO and an Executive Director on the Board in 2008, and in 2017 was also appointed COO of the company. He is the founding scientist of the company’s PI3K-p110β/δ and HDAC6 programs. Previously, Stephen held…

Read more

Simon Jones  Chief Financial Officer

Simon joined Karus in 2012. After graduating in Physics from the University of Warwick, he qualified as a Chartered Accountant in 1992 with the international accountancy firm, Ernst & Young and subsequently held positions in a number…

Read more

Elisabeth Bone  Head of Pre-clinical Development

Liz graduated in Natural Sciences from the University of Cambridge and was awarded a PhD in Biochemistry/Molecular Pharmacology from Sheffield University. She held various postdoctoral positions in the UK (Birmingham and Manchester) and …

Read more

Philip Beer  Head of Translational Medicine

Philip is a physician scientist with expertise in cancer biology and precision oncology. He trained as a clinical haematologist at Imperial College, London, where he developed specialist knowledge around the laboratory diagnosis and treatment of h…

Read more

James Dow  Head of Clinical Pharmacology and DMPK

Jim graduated in Biochemistry from the University of Strathclyde and obtained a PhD in drug metabolism from the University of Glasgow. He has over 30 years’ experience in the pharmaceutical and biotechnology industries, in Clinical Pharmacol…

Read more